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Summary: An evaluation of a heterogeneous enzyme immunoassay for determination of triiodothyronine in serum
(Enzymun-Test® T3, Boehringer Mannheim) is presented. The enzyme immunoassay was compared with the labora-
tory routine radioimmunoassay. The precision of both assays was satisfactory at triiodothyronine concentrations
between 1.0 and 8.0 nmol/1 (coefficients of variation from day to day < 10%). Average recoveries of triiodothyronine
in pool sera ranged with the Enzymun-Test T3 from 96-104% and with the radioimmunoassay from 88-111 %. A
comparison of the results obtained by Enzymun-Test® T3 and the radioimmunoassay in a series of 103 patients
showed a good correlation between both methods. ,-thyroxine did not cause a relevant cross-reaction in the enzyme
immunoassay. About 20 unknown samples can be analyzed in triplicate by Enzymun-Test® T3 within 260 minutes.
Bestimmung von Triiodthyronin im Serum mittels Enzym- und Radioimmunotest - Eine vergleichende Studie
Zusammenfassung: Es wird über die Erprobung eines heterogenen Enzymimmunotests zur Bestimmung von Triiod-
thyronin im Serum (Enzymun-Test® T3, Boehringer Mannheim) berichtet. Der Enzymimmunotest wird mit einem
Radioimmunotest verglichen, welcher gegenwärtig als Routineverfahren eingesetzt ist. Die Präzision beider Tests war
bei Triiodthyroninkonzentrationen zwischen 1,0 und 8,0 nmol/1 zufriedenstellend (Variationskoeffizienten von Tag
zu Tag < 10%). Die mittleren Wiederfindungen von Triiodthyronin in Poolseren lagen mit dem Enzymun-Test T3 bei
96-104% und mit dem Radioimmunotest bei 88-111%. Ein Vergleich der Ergebnisse, welche mit dem Enzymun-
Test® T3 und dem Radioimmunotest bei einer Serie von 103 Patienten erhalten wurde, zeigte eine gute Korrelation
beider Methoden. L-Thyroxin bewirkte im Enzymimmunotest keine relevante Kreuzreaktion. Etwa 20 unbekannte
Proben können als Dreifachbestimmungen mit dem Enzymun-Test® T3 in 260 Minuten durchgeführt werden.
Introduction presented, which has recently become commercially
available. As there is no reference method for triiodo-
During the last few years enzyme immunoassays have thyronine the enzyme immunoassay was compared with
gained importance in routine diagnosis (1). So far in the
 Qur ra(jjoimmunoassay, which is used as the present
field of in vitro diagnosis of thyroid disorders enzyme
 routine procedure.
immunoassays have been developed for the determina-
tion of thyroxine (2-5), thyfoxine binding capacity (6),
truodothyronine uptake (7), thyrotropin (8, 9, 10), tri-
iodothyronine (2, 12), thyroglobujin (13) and anti-
 Methods
thyroglobulin autqantibody ( 14). In various compara-
tive studies an acceptable correlation between commer- Materials
ciaUy available enzyme immunoassays for the determina- j^
 reagents for Enzymun-Test® T3 were provided for clinical
tion of thyroxine and thyroxine binding capacity and trial by Boehringer Mannheim (D-8132 Tutzing). Kits for the
Strated (15-48). iodothyronine and /,-thyroxine was purchased from Sigma
In this study an evaluation of a heterogeneous enzyme ^^ ^^ £ £^ '^^^
immunoassay for the determination of triiodothyronine Lypho-Check® Radioassay Control Serum was purchased from
(2) (Enzymun-Test® T3, Boehringer Mannheim) is BioRad Laboratories (D-8000 Munich 50).
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Enzyme immunoassay
Triiodothyronine determinations were performed according to
the manufacturer's instructions with an Eppendorf spectro-
photometer 1101 M (Eppendorf, D-2000 Hamburg 63) equipped
with a flow cell and connected on-line to an electronic data
processing system IBM 1130, which printed out the values of
the absorbances. The further evaluation of the results was per-
formed either graphically by a manual curve-fit or by the com-
puter using an empiric spline interpolation (Forth, A. & Oelle-
rich, M. in prep.). All determinations were performed in tri-
plicate at a wavelength of 405 nm.
Radioimmunoassay
Triiodothyronine determinations by radioimmunoassay were
carried out with a double antibody technique, which is used as
the present routine procedure.
50 ìÀ of serum or Æ,-triiodothyronine standard (A), 400 ìÀ of
barbital buffer containing [125I]I-triiodothyronine (B), 200 ìÀ
of antiserum against Æ,-triiodothyronine (C) and 100 ìÀ of
precipitating antiserum (D) were pipetted by a fully mechanized
pipetting system (Automatische RIA-Vorbereitung, Braun-Mel-
sungen, D-3508 Melsungen) and then incubated for 18 hours at
room temperature. The long incubation period was chosen
primarily for organizational reasons. The samples are then
centrifuged for 15 minutes at 2400 £ and the supernatant dis-
carded. The pellet is washed once with 1 ml of bidistilled water.
The antibody-bound radioactivity is measured using gamma
counters (Packard Instruments, D-6000 Frankfurt/M., Berthold,
D-7547 Wildbad). All samples were analyzed in duplicate.
Standard curves were calculated by "spline function" (19) using
a Diehl Alphatronic calculator (Diehl, D-8500 N rnberg).
Reagent A
Triiodothyronine-free serum was prepared according to Mem-
hold & Wenzel (20). Charcoal (200 g, Norit A, Serva, D-6900
Heidelberg) was added to pool serum (11), stirred overnight at
4 °C and then centrifuged for 8 h at 20000£. The supernatant
was filtered using quartz wool. The values of total protein
(biuret-method) and those of electrophoresis determined by use
of an Olympus Hite System (11) (Olympus Optical Co., D-2000
Hamburg) pointed to minor differences between the charcoal-
extracted serum (total protein 67 g/1; fractions: albumin 0.628,
cq-globulin 0.027, a2-globulin 0.099,0-globulin 0.065, ã-globu-
lin 0.181) and the starting material (total protein 70 g/1; frac-
tions: albumin 0.622; c^-globulin 0.034;«2-globulin 0.101;
0-globulin 0.094;7-globulin 0.149). Triiodothyronine-free
serum was spiked using lyophilized Æ,-triiodothyronine (100 ìg,
RIA standard reagent, Henning, D-1000 Berlin) (0.77-
24.6 nmol/1). In some of the recovery experiments 50 mg of
Z-triiodothyronine (Sigma, D-8021 Taufkirchen) was dissolved
in 1 ml of 0.2 mol/1 NaOH. After dilution with distilled water
(1:106) the final solution was used to spike triiodothyronine-
free serum.
Reagent B
Barbital buffer (pH 8.4) contained: 80 mmol/1 barbital
(5,5'-diethyl-barbituric acid-sodium salt) (Merck, D-6100 Darm-
stadt), 10 mg/1 rabbit ã-globulin (Serva, D-6900 Heidelberg),
1 g/1 human serum albumin (Behring, D-3550 Marburg),
2.77 mmol/1 ammonium salt of l-anilino-8-naphthalene-sulphonic
acid (Serva, D-6900 Heidelberg), 32 pmol/1 ["5I]L-triiodo-
thyronine (specific activity 65 000 MBq/ìéçïÉ) (Rohstoffein-
fuhr, D-4000 D sseldorf), 0.5 mmol/1 merthiolate (sodium salt
of ethylmercurithiosalicylic acid) (Merck, D-6100 Darmstadt).
Reagent C
Triiodothyronine-bovine-serum-albumin-conjugate was prepared
according to Oliver (21) andHesch (22) by coupling X-triiodo-
thyronine-methylester-hydrochloride (Henning, D-10 Berlin)
to bovine serum albumin (Behring, D-3550 Marburg) using
l-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride
(Serva, D-6900 Heidelberg). Two mg of triiodothyronine-bovine-
serum-albumin-conjugate dissolved in 1 ml complete/tewwTs
adjuvant (Behring, D-3550 Marburg) and 0.15 mol/I sodium
chloride solution (volumes 0.5 ml + 0.5 ml) were subcutaneously
injected at various places on the back of rabbits every 14 days.
The immunisation was performed for a period of two months.
The reaction medium of the assay contains triiodothyronine-
antiserum in a final dilution of 1:50000 (affinity constant
1.02-1011 1/mol).
Reagent D
As precipitating antiserum anti-rabbit 7-globulin from donkey
(Wellcome, D-3006 Gro burgwedel) was used (final dilution in
the reaction medium 1:144).
Reference range
With the T3-radioimmunoassay the reference range used was
1.2-3.7 nmol/1. this reference range was established by the
analysis of 150 samples from clinically euthyroid female and
male patients (age: 20-65 years). As the results showed a nor-
mal distribution the reference range was calculated from the
mean value and two standard deviations.
This reference range was examined for its validity for the patient
collective tested in this study. It was found that the median of
the results obtained with this collective by radioimmunoassay
and Enzymun-Test® T3 was in each case in the middle of the
above mentioned reference range. Therefore it appeared to be
justified to use this reference range with both methods.
Determination of the detection limit
With the Enzymun-Test® T3 the detection limit for triiodo-
thyronine was determined according to Kaiser (24) as the mean
value plus the 3 fold standard deviation of a series (n - 20) from
triiodothyronine-free pooled human serum.
Results and Discussion
Imprecision
At diagnostically relevant triiodothyronine concentra-
tions between 1.0 and 8.0 nmol/1 the coefficients of
variation of mean values from triplicate determinations
ranged from day to day with Enzymun-Test® T3 from
3.6-10.2% (tab. 1). With the radioimmunoassay coeffi-
cients of variation of mean values from duplicate deter-
minations of 3.0—12.7% were observed at triiodo-
thyronine concentrations between 0.9 and 7.5 nmol/1.
Recovery
Average recoveries of triiodothyronine added to pooled
human serum and to triiodothyronine-free human pool
serum are shown in table 2. At triiodothyronine concen-
trations between 0.77 and 7.68 nmol/1 the recovery
ranged with the Enzymun-Test® T3 from 96-104%
and with the radioimmunoassay from 88—111%.
Method comparison study
Furthermore the triiodothyronine concentration was
measured by Enzymun-Test® T3 and radioimmuno-
assay in 103 specimens from patients. The correlation
between the results was good (r = 0.976). The slope of
the line and the intercept were calculated using the
standardized principal component analysis (23). The
values of slope and intercept were 1.01 and 0.07 nmol/1.
The mean value of the results obtained by Enzymun-
Test® T3 (y: 3.53 ±1.81 nmol/1) agreed well with that
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Tab. 1. The imprecision from day-to-day of the Enzymun-Test® Tj and radioimmunoassay for determination of triiodothyronine in
serum. Assays were performed by radioimmunoassay in duplicate and by Enzymun-Test® T3 in triplicate on various days and
the mean values were used for calculation of the precision.
Enzymun-Test® TS
Triiodothyronine
÷ CVa)
(nmol/1) (%)
nb)
Radioimmunoassay
Triiodothyronine
x CVa)
(nmol/1) (%)
nb)
T3 spiked serum samples0)
0.77 nmol/1
1.54 nmol/1
3.07 nmol/1
6.14 nmol/1
7.68 nmol/1
Boehringer Mannheim control serum
Lypho check I
Lypho check II
Lypho check III
0.75
1.60
2.98
6.08
7.63
1.60
-
-
—
18.7
6.9
6.0
3.6
4.2
10.2
—
—
—
12
12
12
12
12
19
-
-
—
-
2.69
5.65
6.97
-
0.9
3.5
7.5
—3.0
3.5
5.0
-
12.7
4.5
7.6
—
5
5
5
-
42
42
42
f) mean value with coefficient of variation
b) number of days
c) triiodothyronine-free charcoal-extracted human pool serum was spiked with Æ,-tri-
iodothyronine (Sigma)
Tab. 2. The recovery of triiodothyronine by Enzymun-Test® T3 and radioimmunoassay in spiked serum samples.
L-Triiodothyronine
weighed in (nmol/1)
Recovery of triiodothyronine
Enzymun-Test® T3
(nmol/1) (%)
Radioimmunoassay
x
1)
(nmol/1) (%)
Pooled human serum,
T3 Henning
0.77
1.54
3.07
6.14
T3-free pooled human serum,
T3 Sigma
1.89
2.66
3.43
4.92
7.68
100
100
99
96
4
4
4
4
4
1) Mean value 2) Number of day s
2.07
3.15
3.66
5.30
8.03
111
101
103
98
4
4
4
4
4
0.77
1.54
3.07
6.14
7.68
0.75
1.60
2.98
6.08
7.63
103
104
97
99
99
12
12
12
12
12
-
—
2.69
5.65
6.97
-
—
88
92
91
-
—
5
5
5
of the results determined by radioimmunoassay (x: 3.57
± 1.80 nmol/1; t-v l e 0.958, ñ > 0.15). The correlation
between both methods was satisfactory, even when
samples from pregnant women with elevated thyroxine
binding capacity (114-145%) were compared (fig. 1).
Specificity
The cross-reactivity of thyroxine in the enzyme immuno-
assay was tested using spiked human charcoal^extracted
serum (tab. 3). As the reference range of thyroxine is
relatively low (51.5-167.3 nmol/1), a relevant inter-
ference of this compound is usually not to be expected.
Interferences
Haemoglobin concentrations up to 1.0 g/1 showed no
relevant interference in the Enzymun-Test® T3. In
severely haemolytic specimens, however, the recovery
of triiodothyronine was distinctly reduced (tab. 4).
With severely icteric and lipaemic serum samples the
results obtained by Enzymun-Test® T3 and radio-
J. Clin. Chem. Clin. Biochem. / VoL 19,1981 / No. 7
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Tab. 3. Cross-reactivity of thyroxine in the Enzymun-Test® T3.
Z-Thyroxine
weighed in1)
(nmoi/i)
200
1000
2000
2500
3000
Triiodothyronine
÷ ±s
(nmol/i) (nmol/1)
3.23
3.23
3.50
4.19
4.92
5.84
0.12
0.08
0.43
Recovery
(%)
100
100
108
130
152
181
n2)
4
3
4
4
1
1
Triiodothyrpnine
÷ Recovery
(nmol/i) (%)
1.61
1.70
2.15
2.46
3.46
4.15
100
106
134
153
215
258
n2)
2
2
2
2
2
2
1) Æ,-thyroxine was added to charcoal^extracted human pool serum containing 3.23 nmol/1 and 1.61 nmol/1 triiodothyronine
respectively.
2) number of day s
b. 4. The influence of haemoglobin on the results of the
Enzymun-Test® T3.
£ 0.0 2.0 4.0 6.0 8.0
Triiodothyronine (Radioimmunoassay) [nmol/l]
Fig. 1. Serum triiodothyronine concentrations as measured by
enzyme immunoassay Enzymun-Test® T3 and radio-
immunoassay (n = 103). Slope: 1.01, intercept:
0.07 nmol/1, correlation coefficient: 0.976. Diamonds
represent serum samples from pregnant women with
elevated thyroxine binding capacity (114-145%).
Haemoglobin
(g/D
0
0.5
1.0
2.5
5.0
7.0
14.0
28.0
Triiodothyronine
÷ Recovery
(nmol/1) (%)
1.50
1.46
1.46
1.31
1.31
1.23
0.61
0.61
100
97
97
87
87
82
41
41
n1)
4
2
2
2
2
1
1
2
Number of days
immunoassay did not show a significant difference
(tab. 5).
Detection limit
With the Enzymun-Test® T3 a detection limit for tri-
iodothyronine of 0.23 nmol/1 was observed under our
experimental conditions. The measuring range of this
assay (0.23-9.22 nmol/1) is comparable with that of the
radioimmunoassay. The detectability of both assays
appears to be adequate for clinical requirements.
Tab. 5. Comparison of triiodothyronine concentrations determined by Enzymun-Test® TS and radioimmunoassay in icteric and
lipaemic serum samples.
Enzymun-Test® J3
Triiodothyronine
÷ ± s n1)
Biliiubin (ìéçïÀ/À)
÷: 314 range: 24-823
Triglycerides (mmol/1)
x: 18.2 range: 2.5-71.4
(nmol/1)
2.1
3.0
(nmoi/1)
1.2*) 14
2.02) 12
Radioimmunoassay
Triiodothyronine
÷ ± s
(nmol/l)
2.0
3.1
(nmol/1)
1.1
2.2
n1)
14
12
1) Number of serum samples
2) Differs not significantly from the corresponding value determined by radioimmunoassay (p > 0.40, t-Test)
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Practicability
The Enzymun-Test® T3 is easy to perform. 20 unknown
triplicate samples can be analyzed by this assay within
about 260 minutes. For evaluation of the results an
empiric spline interpolation proved to be suitable
(Forth, A. & Oellerich, M. in prep.). Using this curve-
fitting method the recovery of triiodothyronine
(0.77-7.68 nmol/1, n = 6) was on average 102% (range:
99—107%) between and 100% at the calibration points.
in serum, is comparable with the laboratory radio-
immunoassay used as the reference method. In accord-
ance with the results presented here the Enzymun-Test®
T3 showed mainly a good correlation with various other
radioimmunological procedures (25). Compared with
the radioimmunoassay the Enzymun-Test® T3 has the
advantage that no radioactive material is used and the
reagents have a longer shelf life.
Conclusion
In summary it can be concluded that the enzyme immuno-
assay, tested for the determination of triiodothyronine
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